海南省居民肝癌死亡与期望寿命损失情况分析

Analysis of liver cancer death and life expectancy loss among residents in Hainan province

目的 分析海南省2018年居民肝癌死亡情况及其对期望寿命的影响,为政府制定肝癌防控措施提供依据。方法 收集2018年海南省全员人口数据库人口和死亡数据以及海南省疾病预防控制中心居民死亡监测数据,计算海南省居民肝癌死亡率、中国人口标化率(中标率)、世界人口标化率(世标率)和肝癌造成的期望寿命损失。结果 2018年海南省居民肝癌死亡率为30.57/10万,中标率为23.19/10万,世标率为22.70/10万。2018年海南省居民肝癌导致的期望寿命损失为0.62岁,男性和女性居民肝癌导致的期望寿命损失分别为0.89和0.24岁,城市和农村居民肝癌导致的期望寿命损失分别为0.54和0.66岁。结论海南省居民肝癌死亡率及其导致的期望寿命损失较高,为降低肝癌死亡率,提高海南省居民人均期望寿命,建议政府增强全民肝癌防治意识,扩大乙肝疫苗接种范围,加强肝癌致病因素防控,推进肝癌筛查及早诊早治工作。

Objective To analyze the death of liver cancer residents in Hainan province in 2018 and its influence on life expectancy,and to provide basis for the government to formulate prevention and control measures for liver cancer.Methods The population and death data of the whole population database of Hainan province and the death monitoring data of residents in the Center for Disease Control and Prevention of Hainan Province in 2018 were collected.The death rate of liver cancer,age-standardized rate by Chinese standard popu-lation(ASR China)of mortality,age-standardized rate by world standard population(ASR world)of mortality,and the life expectancy loss caused by liver cancer were calculated.Results In 2018,the death rate of liver cancer in Hainan province was 30.57/100000.ASR China of mortality was 23.19/100000,ASR world of mortality was 22.70/100000.In 2018,the life expectancy loss due to liver cancer in Hainan province was 0.62 years for residents in Hainan province,0.89 years and 0.24 years for male and female residents,and 0.54 years and 0.66 years for urban and rural residents,respectively.Conclusions The death rate of liver cancer and the loss of life expectancy due to liver cancer are relatively high in Hainan province.In order to reduce the death rate of liver cancer and improve the average life expectancy of residents in Hainan province,it is suggested that the government should enhance the awareness of prevention and treatment of liver cancer,expand the scope of hepatitis B vaccination,strengthen the prevention and control of pathogenic factors of liver cancer,and promote the screening and early diagnosis and treatment of liver cancer.